View in EDS HTML Full Text PDF Full Text

Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan.

Saved in:
Bibliographic Details
Title: Real-World Treatment Outcomes of Different Sequencing Options with Daratumumab, Lenalidomide, and Dexamethasone in Patients with Transplant-Ineligible Multiple Myeloma in Japan.
Authors: Suzuki, Kazuhito1 (AUTHOR), Fujimori, Yuma2 (AUTHOR) yfujimor@its.jnj.com, Sakai, Chika1,2 (AUTHOR), Tsuchiya, Hiroaki2 (AUTHOR), Koroki, Yosuke2 (AUTHOR)
Source: Cancers. May2025, Vol. 17 Issue 9, p1389. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers17091389